One of the most consistent pathological features in Alzheimer's disease (AD) is a cortical cholinergic hypofunction which results from degeneration of cholinergic neurons located within the basal forebrain. The cholinergic deficit occurs early in the disease process and correlates with disease severity and duration. Additionally, there is a large experimental and clinical literature demonstrating that the cholinergic basal forebrain system is involved in normal and pathological memory processes. These data indicate the contribution of this system tot eh major symptomatology of AD. Converging lines of evidence indicate that the development and maintenance of cholinergic basal forebrain neurons is dependent upon the trophic factor nerve growth factor (NGF). Based upon these data, it was suggested that impaired NGF trophism underlies the degeneration of basal forebrain neurons in AD. Initial studies demonstrating normal NGF synthesis and expression of its low affinity NGF receptor in AD diminished enthusiasm for this view. However, NGF trophism occurs through a series of molecular events. We have recently demonstrated that NGF transport mechanisms are defective in AD and hypothesize this event may mediate the degenerative events seen in the AD basal forebrain. In AD, we found a reduced expression of NGF- immunoreactivity within the cholinergic basal forebrain and an accumulation of NGF within the cerebral cortex. In the present series of studies.
Specific Aims 1 and 2 will establish the extent to which diminished NGF- immunoreactivity within the basal forebrain and accumulated NGF protein within the cerebral cortex is associated with the clinical progression of AD. Well characterized patients with mild, moderate, and severe dementia will be compared to age-matched controls. The immunohistochemical expression of NGF within the basal forebrain and NGF protein within different regions of the cerebral cortex will be quantified and compared between patient populations.
Specific Aims 3 will utilize the fact that subfields of the cholinergic basal forebrain are selectively vulnerable in AD to assess the degree to which reduced transported NGF is associated specifically with neural degeneration. NGF-immunoreactivity will be quantified and the expression of NGF-ir will be compared between cholinergic septal.diagonal neurons which are sustained in AD and neurons of the nucleus basalis which extensively degenerate in AD.
Specific Aim 4 will focus upon the mechanisms responsible for the diminished NGF- immunoreactivity in the basal forebrain and accumulated NGF protein within the cortex in AD. We hypothesize that these events are due to an impairment in the high affinity trkA receptor. This is the receptor which transduces the NGF signal. In situ hybridization will be used to determine whether trkA mRNA is altered in AD as a function of disease progression. These studies will help establish the role of impaired NGF trophism in CBF degeneration and the progression of clinical dementia in AD. The data derived from these studies will be integrated with others in the program project which are also investigating radiologic and pathologic parameters of disease progression in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG009466-09
Application #
6295527
Study Section
Project Start
1999-05-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Mahady, Laura J; Perez, Sylvia E; Emerich, Dwaine F et al. (2017) Cholinergic profiles in the Goettingen miniature pig (Sus scrofa domesticus) brain. J Comp Neurol 525:553-573
Cade, Brian E; Gottlieb, Daniel J; Lauderdale, Diane S et al. (2016) Common variants in DRD2 are associated with sleep duration: the CARe consortium. Hum Mol Genet 25:167-79
Mufson, Elliott J; Malek-Ahmadi, Michael; Perez, Sylvia E et al. (2016) Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging 37:147-153
Lim, Andrew S P; Bennett, David A; Buchman, Aron S (2016) Response to Letter Regarding Article, ""Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Community-Dwelling Older People"". Stroke 47:e175
Lim, Andrew S P; Yu, Lei; Schneider, Julie A et al. (2016) Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Community-Dwelling Older People. Stroke 47:516-8
Perez, Sylvia E; He, Bin; Nadeem, Muhammad et al. (2015) Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biol Psychiatry 77:693-703
Ramanan, Vijay K; Risacher, Shannon L; Nho, Kwangsik et al. (2015) GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain 138:3076-88
Beckett, Laurel A; Donohue, Michael C; Wang, Cathy et al. (2015) The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding. Alzheimers Dement 11:823-31
Sohail, Shahmir; Yu, Lei; Bennett, David A et al. (2015) Irregular 24-hour activity rhythms and the metabolic syndrome in older adults. Chronobiol Int 32:802-13
Alldred, Melissa J; Lee, Sang Han; Petkova, Eva et al. (2015) Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Brain Struct Funct 220:2983-96

Showing the most recent 10 out of 197 publications